| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Sionna Therapeutics, Inc. (SION) has 9 insiders with recent SEC Form 4 filings, including 0 buys and 18 sells. SION is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 2.47M | $116.93M | - | |
| Dir | 2.47M | $116.93M | - | |
| Dir | 2.31M | $109.31M | - | |
| 10% | 2.20M | $104.06M | - | |
| CEO | 436.1K | $20.64M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 7, 2026 | Orbimed Advisors LLC66 | Director | Sell | 85,918 | $44.86 | $3,854,281.48 | -3.4% | - | - | |
| Jul 7, 2026 | Thompson Peter A.63 | Director | Sell | 85,918 | $44.86 | $3,854,281.48 | -3.4% | - | - | |
| May 27, 2026 | Thompson Peter A.63 | Director | Sell | 101 | $44.49 | $4,493.49 | - | - | - | |
| May 27, 2026 | Orbimed Advisors LLC66 | Director | Sell | 101 | $44.49 | $4,493.49 | - | - | - | |
| May 11, 2026 | Thompson Peter A.63 | Director | Sell | 292,952 | $45.62 | $13,364,064.50 | -3.4% | - | - | |
| Apr 18, 2026 | Orbimed Advisors LLC66 | Director | Sell | 55,345 | $44.67 | $2,472,342.92 | -0.9% | +4.0% | - | |
| Apr 18, 2026 | Thompson Peter A.63 | Director | Sell | 55,345 | $44.67 | $2,472,342.92 | -0.9% | +4.0% | - | |
| Apr 16, 2026 | Thompson Peter A.63 | Director | Sell | 510,583 | $44.94 | $22,945,043.50 | -5.0% | -1.9% | - | |
| Apr 16, 2026 | Orbimed Advisors LLC66 | Director | Sell | 510,583 | $44.94 | $22,945,043.50 | -5.0% | -1.9% | - | |
| Dec 24, 2025 | Thompson Peter A.63 | Director | Sell | 33,356 | $44.55 | $1,486,009.80 | -0.9% | -21.0% | - |